Assuit University hospitals
Asyut, Egypt
NCT Number: NCT06959485
Diabetic kidney disease (DKD) is the most significant cause of end-stage kidney disease (ESKD). Albuminuria, evolving from microalbuminuria to nephrotic-range proteinuria, is a clinical hallmark of diabetic nephropathy (DN). It develops in about a third of diabetic patients and is considered an independent risk factor in the progression of DN and for all-cause mortality.
Trial opening soon.
Get Notified10 year–17 year
All sexes
Interventional
Not applicable
Asyut, Egypt
According to the International Diabetes Federation's report, over 530 million people worldwide have diabetes . About one-third of diabetic patients develop diabetic nephropathy (DN) after the incubation period, which may last several years.
Diabetic kidney disease (DKD) is the most significant cause of end-stage kidney disease (ESKD). Albuminuria, evolving from microalbuminuria to nephrotic-range proteinuria, is a clinical hallmark of diabetic nephropathy (DN). It develops in about a third of diabetic patients and is considered an independent risk factor in the progression of DN and for all-cause mortality.
The management of diabetes includes lifestyle modifications, pharmacological interventions, and emerging therapies such as hyperbaric oxygen therapy (HBOT). It involves exposing patients to high levels of oxygen in a pressurized chamber, leading to various physiological effects .
HBOT increases the level of oxygen in tissues by complete saturation of haemoglobin and increasing the partial pressure of oxygen dissolved in plasma. This enables oxygen to diffuse into tissues compromised by acute inflammation and microvascular disease and dysfunction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Standard diabetes and CKD management
Time frame: 6 months
to estimate urinary albumin-to-creatinine ratio in patients suffering form diabetic kidney disease
Contact information is provided by the study sponsor or research team.
Ashraf Anwar Thabet, professor
CONTACT
Hodna Abdullah Ahmed, MSC
CONTACT
Assiut University
Other
Oxygen Therapy in Diabetic Kidney Disease and Its Effect on Proteinuria and Blood Glucose Level
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07717697
Diabetes Complications, Diabetes Mellitus
View Trial DetailsNCT07707518
Diabetes Complications, Diabetes Mellitus
Chongqing, Chongqing Municipality, China
View Trial DetailsNCT07657351
Diabetes Complications, Diabetes Mellitus
Yunlin, Taiwan
View Trial DetailsNCT07523867
Cardio-Renal Syndrome, Cardiovascular Diseases
View Trial Details